Alexium International Group Limited · ASX:AJX
Alexium International — Q4 FY2026 Earnings Presentation
10 slides from Alexium International's earnings presentation, Jul 31, 2026
Slide 1: Alexium International Group Limited 4Q26 Results Presentation
ALEXIUM INTERNATIONAL GROUP LIMITED 4Q26 Results Presentation ABN 91 064 820 408 31st July 2026 PRESENTED IN US DOLLARS
Slide 2: Disclaimer
Disclaimer To the maximum extent permitted by law, the information contained in this presentation is given without any liability whatsoever being accepted by Alexium International Group Limited (Alexium) or any of its related entities or their respective directors or officers, employees, advisors an
Slide 3: Contents
• 4Q26 Results Summary • Trading Update CONTENTS • Operating Plan
Slide 4: 4Q26 Results Summary
4Q26 Results Summary Consolidated Statement of Profit & Loss Financial Review Revenue dropped in the last quarter due to $200K sales returns relating to a production issue in our Dayton OH facility. The problem has now been remediated and will not be ongoing. Relating to the sales returns above
Slide 5: Trading Update
Trading Update During the quarter, Alexium identified and successfully resolved a production issue at the Dayton Facility, bolstered the management team with a COO appointment, and saw good momentum on the Sales & Technology front. Operations During the quarter, the manufacturing side of the busin
Slide 6: Commercial Update
Commercial Update In Q4, significant progress was made in three key commercial areas. Additionally, there were new customer requests for mPCM for non-bedding markets (furniture, building materials, and apparel), dehumidification for furniture, and flame-resistant coatings (AlexiShield) for transport
Slide 7: Operations Plan – Update Overview
Operations Plan – Update Overview 1. Maximize 2. Capacity 3. Capacity Efficiency of Expansion Expansion Existing via Labor via Capital Assets Utilization Expenditures Transition to a Manufacturing-Centred Operating Model: The Microtek Laboratories acquisition was completed in Q3, thus accelerating t
Slide 8: Operations Plan – Q4 Updates (Phase 1)
Operations Plan – Q4 Updates (Phase 1) Phase 1: Maximize Efficiency of Existing Assets The priority is to achieve maximum operational efficiency from the existing manufacturing assets at the Dayton facility in their current configuration. Key Updates: Process stabilization and standardization: The
Slide 9: Operations Plan – Q4 Updates (Phase 2 & 3)
Operations Plan – Q4 Updates (Phase 2 & 3) Phase 2: Capacity Expansion via Labor Utilisation The initial strategy to increase capacity through incremental manpower additions, rather than capital expenditures has been amended due to evident bottlenecks that will see greater efficiencies realised if p
Slide 10: Summary
Summary Overview: Q4 FY26 was a frustrating period for Alexium. The Company entered the Quarter with strong momentum after the successful closing of the acquisition of the Microtek Laboratories business and early wins from the combination of two of the market leaders in microencapsulation of phase
Alexium International Group — Q4 FY2026 Earnings Presentation on 6ix